Histone deacetylase HDAC1 expression correlates with the progression and prognosis of lung cancer: A meta-analysis
- PMID: 28767587
- PMCID: PMC5626141
- DOI: 10.1097/MD.0000000000007663
Histone deacetylase HDAC1 expression correlates with the progression and prognosis of lung cancer: A meta-analysis
Abstract
Background: Histone deacetylase 1 (HDAC1) is an important epigenetic factor, and is thought to be associated with the progression and prognosis of some types of cancer. HDAC1 has been reported to be overexpressed in lung cancer, but the correlation between HDAC1 overexpression and the clinical features or prognosis of lung cancer is controversial. In this study, we investigated the potential association between HDAC1 and lung cancer.
Materials and methods: Embase, Web of Science, PubMed, and other sources were searched for relevant studies. Pooled odds ratios (ORs) or hazard ratios (HRs) with 95% confidence interval (CI) were calculated to evaluate the association of HDAC1 with lung cancer risk.
Results: Eight eligible studies were included in the final meta-analysis. We found that HDAC1 mRNA or protein expression was closely associated with the differentiation grade of lung cancer (OR = 2.36, 95% CI = 1.14-4.87, P = .02). In addition, the protein expression level of HDAC1 in squamous cell carcinoma was higher than that in adenocarcinoma (OR = 1.81, 95% CI = 1.13-2.90, P = .01). Finally, HDAC1 mRNA or protein expression was negatively correlated with the overall survival rate of patients with lung cancer (HR = 2.40, 95% CI = 1.48-3.88, P = .0004).
Conclusion: In this meta-analysis, our results suggest that HDAC1 may serve as a good diagnostic and prognostic marker for lung cancer.
Conflict of interest statement
The authors have no conflicts of interest to disclose.
Figures







Similar articles
-
The expression of histone deacetylase HDAC1 correlates with the progression and prognosis of gastrointestinal malignancy.Oncotarget. 2017 Jun 13;8(24):39241-39253. doi: 10.18632/oncotarget.16843. Oncotarget. 2017. PMID: 28424407 Free PMC article.
-
Prognostic and clinical significance of histone deacetylase 1 expression in breast cancer: A meta-analysis.Clin Chim Acta. 2018 Aug;483:209-215. doi: 10.1016/j.cca.2018.05.005. Epub 2018 May 5. Clin Chim Acta. 2018. PMID: 29738697 Review.
-
Expression of histone deacetylase 1 correlates with a poor prognosis in patients with adenocarcinoma of the lung.Lung Cancer. 2011 Nov;74(2):300-4. doi: 10.1016/j.lungcan.2011.02.019. Epub 2011 Apr 5. Lung Cancer. 2011. PMID: 21466904
-
Histone deacetylase 1 mRNA expression in lung cancer.Lung Cancer. 2004 Nov;46(2):171-8. doi: 10.1016/j.lungcan.2004.03.021. Lung Cancer. 2004. PMID: 15474665
-
The natural tumor suppressor protein maspin and potential application in non small cell lung cancer.Curr Pharm Des. 2010 Jun;16(16):1877-81. doi: 10.2174/138161210791208974. Curr Pharm Des. 2010. PMID: 20337574 Free PMC article. Review.
Cited by
-
Discovery and Development of HDAC Inhibitors: Approaches for the Treatment of Cancer a Mini-review.Curr Drug Discov Technol. 2024;21(6):e230224227378. doi: 10.2174/0115701638286941240217102948. Curr Drug Discov Technol. 2024. PMID: 38415493 Review.
-
Puerarin ameliorates acute lung injury by modulating NLRP3 inflammasome-induced pyroptosis.Cell Death Discov. 2022 Aug 18;8(1):368. doi: 10.1038/s41420-022-01137-8. Cell Death Discov. 2022. PMID: 35977927 Free PMC article.
-
Identification of an autophagy-related gene signature that can improve prognosis of hepatocellular carcinoma patients.BMC Cancer. 2020 Aug 17;20(1):771. doi: 10.1186/s12885-020-07277-3. BMC Cancer. 2020. PMID: 32807131 Free PMC article.
-
Nature's Elixir for Cancer Treatment: Targeting Tumor-induced Neovascularization.Curr Med Chem. 2024;31(32):5281-5304. doi: 10.2174/0109298673282525240222050051. Curr Med Chem. 2024. PMID: 38425113 Review.
-
Development and Validation of a Novel Histone Acetylation-Related Gene Signature for Predicting the Prognosis of Ovarian Cancer.Front Cell Dev Biol. 2022 Feb 18;10:793425. doi: 10.3389/fcell.2022.793425. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35252174 Free PMC article.
References
-
- Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2017. CA Cancer J Clin 2017;67:7–30. - PubMed
-
- Weichert W, Roske A, Niesporek S, et al. Class I histone deacetylase expression has independent prognostic impact in human colorectal cancer: specific role of class I histone deacetylases in vitro and in vivo. Clin Cancer Res 2008;14:1669–77. - PubMed
-
- Halkidou K, Gaughan L, Cook S, et al. Upregulation and nuclear recruitment of HDAC1 in hormone refractory prostate cancer. Prostate 2004;59:177–89. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous